- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/36 - One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Patent holdings for IPC class C07D 239/36
Total number of patents in this class: 262
10-year publication summary
|
26
|
22
|
14
|
21
|
20
|
17
|
11
|
9
|
14
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 410 |
21 |
| Celgene Quanticel Research, Inc. | 154 |
13 |
| Takeda Pharmaceutical Company Limited | 2717 |
10 |
| Sunshine Lake Pharma Co., Ltd. | 621 |
8 |
| Merck Sharp & Dohme Corp. | 2183 |
7 |
| Neurocrine Biosciences, Inc. | 452 |
7 |
| ASKA Pharmaceutical Co., Ltd. | 99 |
5 |
| Glenmark Pharmaceuticals S.A. | 115 |
5 |
| z Factor Limited | 13 |
5 |
| Centessa Pharmaceuticals (UK) Limited | 60 |
5 |
| Novartis AG | 10306 |
4 |
| F. Hoffmann-La Roche AG | 7837 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 871 |
4 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
4 |
| Glaxo Group Limited | 4378 |
3 |
| Bristol-myers Squibb Company | 4752 |
3 |
| Hoffmann-La Roche Inc. | 3760 |
3 |
| Merck Patent GmbH | 5730 |
3 |
| Bayer Cropscience AG | 1865 |
3 |
| Sumitomo Chemical Company, Limited | 9029 |
3 |
| Other owners | 142 |